Financial Press


PTA-News: Dr. Hönle AG: Operating result of the Hönle Group surges to Euro 30.7 million

14.12.2018

Gräfelfing/München (pta005/14.12.2018/07:40) - According to preliminary figures, Hönle Group generated sales of TEur126,492 in the 2017/2018 financial year, which corresponds to an increase of 24.1% compared to the previous year. The operating result (EBIT) jumped by 101.8% to TEur30,687. The increase in earnings particularly results from the very good business development in the Adhesives segment. In the Equipment & Systems segment, sales and earnings also increased significantly. Earnings before taxes in Hönle Group climbed by 104.3% to TEur30,396 and consolidated net income by 108.6% to TEur21,726. This corresponds to earnings per share of Eur3.94 (PY: Eur1.89). Earnings margins also improved as a result of the positive business development: EBIT margin increased from 14.8% to 23.9% and net return on sales from 10.2% to 17.2%.

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast

09.11.2018

Gräfelfing/München (pta024/09.11.2018/12:16) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year 2016/2017, the Company's operating result came to Eur 15.2 million. The strong business development was driven, in particular, by the Adhesives Segment.

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast

09.11.2018

Graefelfing, Munich (pta021/09.11.2018/11:20) - The Hönle Group again raises its forecast for financial year 2017/2018, expecting an operating result (EBIT) of between Eur 30.5 million and Eur 31.5 million instead of the initially projected Eur 26 to Eur 30 million. In financial year 2017/2018, the Company's operating result came to Eur 15.2 million. The strong business development was driven, in particular, by the Adhesives Segment.

read more ...

 

PTA-News: Dr. Hönle AG: Dr. Hönle AG is included in SDAX

06.09.2018

Gräfelfing/München (pta033/06.09.2018/16:50) - Dr. Hönle AG, an innovative technology company located in Gräfelfing near Munich, will be included in the SDAX. Deutsche Börse has passed extensive rule changes for the indices DAX, MDAX, SDAX and TecDAX. As part of this new regulation and due to the significant increase in its market capitalisation, Dr. Hönle AG will be listed on the SDAX as from September 24, 2018.

read more ...

 

PTA-News: Dr. Hönle AG: Operating result surges by 132% to Euro 19.9 million

10.08.2018

Gräfelfing/München (pta006/10.08.2018/08:10) - In the first nine months of financial year 2017/2018, the Hönle Group generated sales revenues of TEur88,750, representing a 23.2% increase year-on-year. The operating result (EBIT) jumped by 132.0% to TEur19,865 in the current financial year. Thus, the Hönle Group generated by far the best result in its more than 40-year corporate history. The increase in earnings is largely attributable to the excellent business development in the Adhesives segment. Orders received from the electronics industry in the smart phones segment, in particular, led to a shape rise in sales and earnings. Earnings before tax (EBT) climbed from TEur8,353 to TEur19,669. After deduction of income taxes, the consolidated profit came to TEur14,208 (PY: TEur5,877), corresponding to earnings per share of Eur2.58 (PY: Eur1.07).

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast to between Euro 26 and 30 million

20.06.2018

Gräfelfing/München (pta030/20.06.2018/16:00) - The Hönle Group expects strong business development, especially in the adhesives segment, and therefore raises its forecast for the 2017/2018 financial year again. Instead of sales of between Eur 115 and 125 million, now sales of between Eur 120 and 130 million are expected. The earnings forecast (EBIT) has been raised from between Eur 22 and 26 million to between Eur 26 and 30 million. The Hönle Group generated sales of Eur 101.9 million and an EBIT of Eur 15.2 million in the 2016/2017 financial year.

read more ...

 

PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR

13.06.2018

Graefelfing, Munich (pta031/13.06.2018/15:33) - Announcement

read more ...

 

PTA-News: Dr. Hönle AG: Operating result surges by 168 % to Euro 15.0 million

18.05.2018

Graefelfing/Munich (pta007/18.05.2018/07:30) - The Hönle Group's sales revenues increased by 28.5 % to TEur 60,671 in the first six months of the 2017/2018 financial year. The operating result surged by 167.6 % to TEur 15,047 due to the high proportion of adhesive revenues. Revenues earned in the Adhesives segment almost doubled in the first half of the financial year. This positive business development is due, in particular, to orders from the electronics industry in the smart phones segment. Earnings before tax (EBT) climbed 172.2 % to TEur 14,919 and the consolidated result was up 181.9 % to TEur 10,765. This corresponds to earnings per share of Eur 1.96 (PY: Eur 0.70).

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG

28.03.2018

Gräfelfing/München (pta028/28.03.2018/21:00) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG

28.03.2018

Gräfelfing/München (pta027/28.03.2018/21:00) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG

28.03.2018

Gräfelfing/München (pta020/28.03.2018/14:00) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG

22.03.2018

Graefelfing, Munich (pta033/22.03.2018/18:49) - Release of Voting Rights Announcement

read more ...

 

PTA-News: Dr. Hönle AG: Hönle reports a great leap in earnings in the first quarter

22.02.2018

Gräfelfing/München (pta010/22.02.2018/08:05) - In the first quarter of financial year 2017/2018, the Hönle Group generated revenues of TEur 29,535, which corresponds to a 33.2 % year-on-year increase. The operating result (EBIT) jumped by 231.8 % to TEur 7,392 in the current financial year. Thus, the Hönle Group generated the best period result in its more than 40-year corporate history for the second consecutive quarter. The increase in earnings is attributable to the excellent business development in the Adhesives segment. In particular, orders received from the electronics industry in the smart phones segment led to a shape rise in sales and earnings. The customer base was further expanded in this segment. Earnings before taxes (EBT) jumped by 239.0 % to TEur 7,319 and the consolidated profit by 246.0 % to TEur 5,200. This corresponds to earnings per share of Eur 0.95 (PY: Eur 0.27). The EBIT margin climbed from 9.7 % in the previous year to 24.4 % in the reporting year. Net profit on sales increased from 6.8 % to 17.6 %.

read more ...

 

PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114, 115, 116 WpHG

29.01.2018

Graefelfing, Munich (pta029/29.01.2018/14:08) - Dr. Hönle AG announces that the following financial reports shall be disclosed:

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group increases consolidated result by 26 %

15.12.2017

Graefelfing, Munich (pta006/15.12.2017/08:05) - Preliminary figures indicate a 9.1 % rise in Hönle Group's revenues to TEur 101,926 in the financial year 2016/2017. The operating result (EBIT) improved by 22.6 % to TEur 15,207. Earnings before taxes climbed by 23.5 % to TEur 14,877 and the consolidated result rose by 25.6 % to TEur 10, 414, corresponding to earnings per share of Eur 1.89 (PY: Eur 1.50). The positive business development is also reflected in improved earnings margins: The EBIT margin rose from 12.9 % to 14.8 % and net profit on sales from 8.9 % to 10.2 %.

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle increases its profit forecast to between Euro 22 and 26 million

04.12.2017

Gräfelfing/München (pta026/04.12.2017/15:30) - The Hönle Group increases its profit forecast (EBIT) for the financial year 2017/2018 from between Eur16 and 18 million to between Eur22 and 26 million. This considerable increase in profit is due to an anticipated strong development of the business, particularly in the segment Adhesives. The number of applications for adhesives in the manufacture of smartphones has been considerably expanded. As a consequence, Hönle anticipates that its business with adhesives in the field of consumer electronics will develop highly positively. In addition, increasing sales and profit in the segments Equipment & Systems as well as Glass & Lamps are assumed. Sales of between Eur105 and 115 million originally anticipated have therefore been adjusted to between Eur115 and 125 million.

read more ...

 

PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR

08.11.2017

Graefelfing, Munich (pta033/08.11.2017/15:50) - Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

04.10.2017

Gräfelfing/München (pta036/04.10.2017/16:42) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

18.09.2017

Graefelfing, Munich (pta016/18.09.2017/10:50) - Release of Voting Rights Announcement

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group increases sales by 4.8% to Euro 72 million in the first nine months

17.08.2017

Gräfelfing, Munich (pta011/17.08.2017/07:40) - In the first nine months of the 2016/2017 financial year, the Hönle Group generated revenue of Eur72,052 thousand or an increase of 4.8% compared to the previous year's period. The operating result (EBIT) came to Eur8,564 thousand, which is slightly below the previous year's figure of Eur8,785 thousand. The temporary decline in earnings is primarily due to restructuring processes in the Equipment & Systems segment. The restructuring processes concern the bundling of several warehouse sites at a new central warehouse in the Munich region and the relocation of the production site from Unterlüß to Gräfelfing. The Hönle Group's earnings before taxes decreased from Eur8,508 thousand to Eur8,353 thousand, while consolidated profit advanced from Eur5,713 thousand to Eur5,877 thousand due to a lower tax burden. This corresponds to earnings per share of Eur1.07 (PY: Eur1.03). The EBIT margin came to 11.8% in the reporting year after 12.3% in the previous year. The net profit on sales ratio dropped from 8.3% to 8.2%.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group increases its operating result by 5,2% to Euro 5.6 million in the first half of the year

19.05.2017

Gräfelfing/München (pta007/19.05.2017/06:55) - In the first six months of the 2016/2017 financial year, revenue generated by the Hönle Group increased by 5.4% to Eur47,228 thousand. Revenue in the first quarter was down on the previous year due to the relocation of a production site of Eltosch Grafix GmbH to Dr. Hönle AG in Gräfelfing near Munich, before returning to growth in the second quarter as expected. The operating result improved by 5.2% to Eur5,623 thousand. Earnings before taxes rose by 6.3% to Eur5,481 thousand, while consolidated net income improved by 7.3% to Eur3,819 thousand. This corresponds to earnings per share of Eur0.70 (previous year: Eur0.64).

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

13.04.2017

Graefelfing, Munich (pta038/13.04.2017/16:25) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

13.04.2017

Graefelfing, Munich (pta036/13.04.2017/16:25) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

29.03.2017

Graefelfing, Munich (pta030/29.03.2017/14:45) - Release of Voting Rights Announcement

read more ...

 

PTA-PVR : Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

29.03.2017

Graefelfing, Munich (pta028/29.03.2017/14:45) - Release of Voting Rights Announcement

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Euro 2.2 million in Q1 and expects jump in earnings in HY2

22.02.2017

Gräfelfing/München (pta007/22.02.2017/07:25) - In the first quarter of financial year 2016/2017, the Hönle Group generated sales revenues of TEur 22,180, which corresponds to a 2.0 % decrease year-on-year. The operating result (EBIT) of TEur 2,228 was below the prior-year's figure of TEur 2,788. The decline in earnings is due to temporarily lower sales revenues generated in the Equipment & Systems segment in the context of the relocation of an Eltosch Grafix GmbH production site to Dr. Hönle AG in Gräfelfing near Munich. The Hönle Group's earnings before tax stood at TEur 2,159 (PY: TEur 2,687) and consolidated net income amounted to TEur 1,503 (PY: TEur 1,878). This corresponds to earnings per share of Eur 0.27 (PY: Eur 0.34). The EBIT margin came to 9.7 % in the reporting year after 12.1 % in the previous year. Net return on sales declined from 8.3 % to 6.8 %.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group achieves operating result of Euro 12.4 million

15.12.2016

Gräfelfing/München (pta007/15.12.2016/07:55) - According to provisional figures, the Hönle Group revenue rose by 1.3 % to TEur 93,415 in the 2015/2016 financial year. After TEur 13,524 in the previous year, the operating result (EBIT) was TEur 12,400 in the year under review. Lower adhesive revenues in the Consumer Electronics segment in the first half of the year, in particular, and the delayed start of production concerning furnaces for the semi-conductor industry are the main reasons for the decline in earnings in the 2015/2016 financial year. Moreover, expenses of about TEur 300 associated with the DRUPA trade fair as well as start-up losses of ca. TEur 300 respecting the newly founded SKC Panacol Ltd. in South Korea had an adverse impact on consolidated earnings.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Eur 8.8 million in the first nine months of the year

16.08.2016

Gräfelfing, Munich (pta018/16.08.2016/11:55) - Sales revenues earned by the Hönle Group increased by 2.4 % to TEur 68,761 in the first nine months of financial year 2015/2016. The operating result (EBIT) declined by 7.5 % to TEur 8,785 due to lower adhesives sales in the area of consumer electronics and one-off factors such as expenses incurred for the DRUPA trade fair and start-up losses for the newly founded SKC Panacol Ltd. in South Korea. The Hönle Group's pretax result contracted from TEur 9,161 to TEur 8,508 and the consolidated net income came to TEur 5,713 (PY: TEur 6,709). This corresponds to earnings per share of Eur 1.03 (PY: Eur 1.19).

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle expects operating result of Euro 12 to 13 million

28.07.2016

Gräfelfing/Munich (pta022/28.07.2016/16:37) - The Hönle Group reduces its expectations for the current financial year. Revenues in the 2015/2016 financial year are expected to amount to Eur 90 to 92 million and the operating result will probably come to between Eur 12 and 13 million. Previously, the Company had assumed that revenues and the operating would be more or less on par with the previous year's level (Eur 92.2 million and Eur 13.5 million, respectively).

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Eur 5.3 million in the first half of the year

20.05.2016

Gräfelfing, Munich (pta006/20.05.2016/08:40) - In the first six months of the 2015/2016 financial year, the Hönle Group's sales revenues of TEur 44,811 were slightly up from the previous year's figure of TEur 44,207. The operating result (EBIT) fell from TEur 6,013 in the previous year to TEur 5,346 in the current financial year. In this context it should be noted, however, that the Hönle Group generated special income of TEur 313 in the previous year from the sale of brand rights concerning adhesives in the consumer goods segment. In addition, the proportion of sales generated by the Equipment and Systems segment was significantly higher than in the previous year, which resulted in a rise in the cost of materials ratio. The pre-tax result (EBT) decreased by 10.5 % to TEur 5,156 and the consolidated result saw a 17.6 % decline to TEur 3,561. This corresponds to earnings per share of Eur 0.64 (PY: Eur 0.76).

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Eur 2.8 million in the first quarter

26.02.2016

Gräfelfing/München (pta005/26.02.2016/07:15) - Sales revenues earned by the Hönle Group increased by 3.9 % to TEur 22,641 in the first quarter of the 2015/2016 financial year. Operating result (EBIT) rose by 5.1 % to TEur 2,788 and earnings before tax by 6.6 % to TEur 2,687. Consolidated earnings saw a 4.3 % increase to TEur 1,878, which correspondents to earnings per share of Eur 0.34 (PY: Eur 0.32). Thus, the EBIT margin came to 12.1 % in the current financial year compared to 12.6 % in the previous year. Net profit on sales remained unchanged at 8.3 %. The Hönle Group's capital ratio stood at 65.0 %.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group increases its Operating Result by 43 % to Eur 13.5 million

15.12.2015

Gräfelfing/Munich (pta006/15.12.2015/06:30) - According to preliminary figures, revenues generated by the Hönle Group in financial year 2014/2015 saw a 12.3 % increase to TEur 92,173. The operating result (EBIT) improved by 42.6 % to TEur 13,524 in the same period. While the pre-tax result climbed 56.4 % to TEur 14,023, the consolidated result grew by 58.9 % to TEur 10,320 which translates into earnings per share of Eur 1.84 (PY: Eur 1.13). The earnings ratios thus also improved considerably in a year-on-year comparison: Despite the still negative earnings contribution on the part of Raesch Quarz (Germany) GmbH, the EBIT margin picked up from 11.3 % to 14.6 %. Net profit on sales grew from 7.9 % to 11.2 %.

read more ...

 

PTA-CMS: Dr. Hönle AG: Publication of Home Member State according to § 2c para. 1 no. 2a WpHG

01.12.2015

Gräfelfing/München (pta013/01.12.2015/10:15) - Dr. Hönle AG announces that its home member state is Germany.

read more ...

 

PTA-News: Dr. Hönle AG: Positive outlook for the Hönle Group

21.08.2015

Gräfelfing/München (pta002/21.08.2015/03:05) - The Hönle Group's sales revenues increased by 9.4 % to TEur 67,166 in the first nine months of the 2014/2015 financial year. At the same time, the operating result (EBIT) surged 49.1 % to TEur 9,494. Earnings before tax (EBT) climbed by 51.6 % to TEur 9.161, while the consolidated result increased by 47.8 % to TEur 6,709. This corresponds to earnings per share of Eur 1.19 (PY: Eur 0.80). The profit ratios thus improved perceptibly when compared to the previous year: Despite a negative earnings contribution by Raesch Quarz (Germany) GmbH, the EBIT margin rose from 10.3 % to 14.1 %. Net return on sales increased from 7.4 % to 10.0 %.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Group increases its operating result by 55 % to Eur 6 million

22.05.2015

Gräfelfing/München (pta003/22.05.2015/06:00) - The Hönle Group's sales revenues increased by 9.3 % to TEur 44,207 in the first six months of the 2014/2015 financial year. At the same time, the operating result (EBIT) surged 55.3 % to TEur 6,013. Earnings before tax (EBT) climbed by 58.8 % to TEur 5,763, while the consolidated result increased by 58.7 % to TEur 4,324. This corresponds to earnings per share of Eur 0.76 (PY: Eur 0.49). The profit ratios thus improved perceptibly when compared to the previous year: Despite a negative earnings contribution by Raesch Quarz (Germany) GmbH, the EBIT margin rose from 9.4 % to 13.8 %. Net return on sales increased from 6.7 % to 9.8 %.

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Joint Venture of Honle Group with SKC Co. Ltd.

20.05.2015

Gräfelfing/München (pta025/20.05.2015/17:07) - The Dr. Hönle AG subsidiary, Panacol Elosol GmbH, concluded today a cooperation agreement with SKC Co. Ltd.. The agreement expresses the mutual will of both parties to establish a joint enterprise in Korea with a view to selling and marketing adhesives and the intent at a later date to develop and produce adhesive products. Panasol Elosol GmbH is to hold a 51 % stake while SKC Co. Ltd. will hold 49% of the shares in the joint company.

read more ...

 

PTA-News: Dr. Hönle AG: Change in the Supervisory Board of Dr. Hönle AG

08.04.2015

Gräfelfing/München (pta023/08.04.2015/16:29) - Professor Dr. Karl Hönle, previously Deputy Chairman of the Supervisory Board took over as Chairman of the Controlling Body of the listed Dr. Hönle AG (ISIN: DE0005157101) and thus succeeds Dr. Hans-Joachim Vits, who has departed from the Supervisory Board. Professor Hönle is one of the founders of Dr. Hönle Aktiengesellschaft and has been a member of the company's Supervisory Board since 1999. He is Professor Emeritus at Munich University, held the chair for Technical Optics and Laser Technology and was an authorized representative for the technology transfer and trade fair participation of Bavarian applied sciences universities. As member of the Panel, Professor Hönle heads the "Labor für Lichttechnik" (GbR) and is a member of the Authorized Standardization Committee for Light Technology at the German Institute for Standardization [Deutsches Institut für Normung (DIN)]. In addition, Professor Hönle is Chief Executive Officer of Dr. Hönle Medizintechnik GmbH.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Eur 2.7 million in the first quarter of the year

26.02.2015

Gräfelfing/Munich (pta002/26.02.2015/05:20) - Sales revenues earned by the Hönle Group jumped 7.6 % to TEur 21,790 in the first quarter of the 2014/2015 financial year, and the corporate group succeeded in improving the operating result (EBIT) by 19.6 % to TEur 2,653. Earnings before tax rose by 20.2 % to TEur 2,520 and consolidated earnings saw a 19.4 % increase to TEur 1,801. This translates into earnings per share of Eur 0.32 (PY: Eur 0.28). Thus, the EBIT margin came to 12.6 % in the current financial year compared to 10.7 % in the previous year. Net profit on sales climbed from 7.5 % to 8.3 % in the same period. The Hönle Group reported an equity ratio of 60.1 %.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle generates operating result of Eur 9.5 million

15.12.2014

Gräfelfing, Munich (pta011/15.12.2014/10:17) - According to preliminary figures, sales revenues earned by the Hönle Group in the 2013/2014 financial year climbed 6.2 % to TEur 82,090.The operating result (EBIT- earnings before interest and tax) saw a 23.1 % increase to TEur 9,483 in the same period. In the previous year, special financial income-related influences amounting to Eur 1,491 led to an increase in the pre-tax result and consolidated net income for the year. At TEur 8,967, EBT (pre-tax result) was therefore only 3.8 % up on the previous year whereas the consolidated result dropped by 3.2 % to TEur 6,495. This translates into earnings per share of Eur 1.13 (PY: Eur 1.20). Adjusted for the special influences, EBT was up 25.5 % and the consolidated result was up 24.4 % on the previous year's level. Despite a clearly negative earnings contribution on the part of Raesch Quarz (Germany) GmbH in the amount of TEur 2,257, Hönle Group succeeded in raising the EBIT margin from 9.8 % to 11.3 %. Net profit on sales declined from 8.7 % to 7.9 % as a consequence of the special influences described above.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle Increases Nine-Month Results to Eur 6.4 million

22.08.2014

Gräfelfing, Munich (pta002/22.08.2014/05:25) - Sales revenues earned by the Hönle Group in the first nine months of financial year 2013/2014 increased by 10.6 % to TEur 61,390. The operating result (EBIT) climbed by 19.5 % to TEur 6,368 in the same period. Pre-tax results grew 26.7 % to TEur 6,044 and consolidated earnings by 29.0 % to TEur 4,539, which translates into earnings per share of Eur 0.80 (PY: Eur 0.61). This development also led to a year-on-year improvement in the earnings ratio: Despite a clearly negative earnings contribution on the part of Raesch Quarz (Germany) GmbH, the Hönle Group succeeded in increasing the EBIT margin from 9.4 % to 10.3 % and net profit margin from 6.3 % to 7.4 %. Equity capital amounted to TEur 48,586 as of 30 June 2014, which corresponds to an equity ratio of 59.9 %.

read more ...

 

PTA-News: Dr. Hönle AG: Hönle's operating result increases by 24 % to Euro 3.9 million in six months

23.05.2014

Graefelfing, Munich (pta009/23.05.2014/08:30) - Sales revenues earned by the Hönle Group increased 11.9 % to TEur 40.445 in the first half of financial year 2013/2014. The operating result (EBIT) climbed 23.8 % to TEur 3,871 and the pre-tax result by 33.5 % to TEur 3,628. Consolidated earnings came to TEur 2,725 (PY: TEur 2,004) which translates into earnings per share of Eur 0.49 (PY: Eur 0.35). Consequently, the income ratio also improved in comparison with the previous year: The EBIT margin picked up from 8.4 % in the prior year's period to the present 9.4 % and net profit on sales from 5.5 % to 6.7 %. The Hönle Group's capital ratio stands at 57.7 % (PY: 58.8 %).

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Hönle generates operating result of Eur 7.7 million in financial year 2012/2013

09.12.2013

Graefelfing/Munich (pta019/09.12.2013/12:20) - According to preliminary figures, the Hönle Group earned revenues of Eur 77.3 million (PY: Eur 72.1 million) in the financial year 2012/2013. The operating result (EBIT) came to Eur 7.7 million (PY: Eur 8.3 million). As reported in the announcement of 26 November 2013, an accounting change led to an additional financial result of Eur 1.5 million in financial year 2012/2013 and of Eur 0.7 million in financial year 2011/2012. Earnings before taxes (EBT) thus improved to Eur 8.6 million after Eur 8.4 million in the previous year. The consolidated net income rose from Eur 6.2 million to Eur 6.7 million, which represents earnings per share of Eur 1.20 (PY: Eur 1.08).

read more ...

 

PTA-Adhoc: Dr. Hönle AG: Changes in accounting impact positively on the Hönle Group's financial result

26.11.2013

Gräfelfing, Munich (pta023/26.11.2013/12:50) - A special effect resulting from accounting changes impacts positively on Hönle Group's financial result in the 2012/2013 financial year.

read more ...

 

PTA-DD: Dr. Hönle AG: Directors' Dealings

18.07.2013

Graefelfing/Munich (pta029/18.07.2013/18:05) - Announcement

read more ...

 

PTA-DD: Dr. Hönle AG: Directors' Dealings

18.07.2013

Graefelfing/Munich (pta027/18.07.2013/18:00) - Announcement

read more ...